Publication: 2521

Phase I study of panobinostat (LBH589) and letrozole in post-menopausal metastatic breast cancer patients
      QxMD      Google Scholar   
Citation:
Clin Breast Cancer vol 16 (2) 82-86
Year:
2016
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Received
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
5
Parents:
363  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA031946, U10 CA033601, U10 CA180821, U10 CA180882, U10 CA180867  
Corr. Author:
 
Authors:
               
Networks:
 
Study
NCCTG-N093B
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
1/2
Keywords:
Phase I, Panobinostat, HDAC inhibitors, metastatic breast cancer, aromatase refractory